Chlamydia pneumoniae induces expression of pro-atherogenic factors through activation of the lectin-like oxidized LDL receptor-1

Pathogens and Disease

Volumn 69, Issue 1, 2013, Pages 1-6

  Campbell, Lee A ^a   Lee, Amy W ^a   Rosenfeld, Michael E ^a   Kuo, Cho chou ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Adhesion molecules; Atherosclerosis; Chlamydia; Glycan; LOX 1 receptor

Indexed keywords

CELL ADHESION MOLECULE; GLYCAN; GLYCOPEPTIDASE; INTERSTITIAL COLLAGENASE; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1 ANTIBODY; RECEPTOR ANTIBODY; STROMELYSIN; UNCLASSIFIED DRUG; OLR1 PROTEIN, HUMAN; OUTER MEMBRANE PROTEIN; POLYSACCHARIDE;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHLAMYDIA TRACHOMATIS; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; HELA CELL LINE; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CHLAMYDIA PNEUMONIAE; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; HOST PATHOGEN INTERACTION; METABOLISM; MICROBIOLOGY; MOUSE; PATHOGENICITY; PHYSIOLOGY;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; CELLS, CULTURED; CHLAMYDOPHILA PNEUMONIAE; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; HOST-PATHOGEN INTERACTIONS; MACROPHAGES; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MICE; POLYSACCHARIDES; SCAVENGER RECEPTORS, CLASS E; UP-REGULATION;

EID: 84900029297     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1111/2049-632X.12058     Document Type: Article

References (28)

1. Blessing E, Nagano S, Campbell LA, Rosenfeld ME & Kuo CC (2000) Effect of Chlamydia trachomatis infection on atherosclerosis in apolipoprotein E-deficient mice. Infect Immun 68: 7195-7197.
2. Blessing E, Campbell LA, Rosenfeld ME, Chough N & Kuo CC (2001) Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice. Atherosclerosis 158: 13-17.
3. Blessing E, Campbell LA, Rosenfeld ME & Kuo CC (2002) Chlamydia pneumoniae and hyperlipidemia are co-risk factors for atherosclerosis: Infection prior to induction of hyperlipidemia does not accelerate development of atherosclerotic lesions in C57BL/6J mice. Infect Immun 70: 5332-5334.
4. Campbell LA & Kuo CC (2004) Chlamydia pneumoniae-an infectious risk factor for atherosclerosis? Nat Rev Microbiol 2: 23-32.
5. Campbell LA, Lee A & Kuo CC (2006) Cleavage of the N-linked oligosaccharide from the surfaces of Chlamydia species affects infectivity in the mouse model of lung infection. Infect Immun 74: 3027-3029.
6. Campbell LA, Puolakkainen M, Lee A, Rosenfeld ME, Garrigues HJ & Kuo CC (2012) Chlamydia pneumoniae binds to the lectin-like oxidized LDL receptor for infection of endothelial cells. Microbes Infect 14: 43-49.
7. Chen M, Kakutani M, Minami M et al. (2000) Increased expression of lectin-like oxidized low density lipoprotein receptor-1 in initial atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol 20: 1107-1115.
8. Draude G, Hrboticky N & Lorenz RL (1999) The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin. Biochem Pharmacol 57: 383-386.
9. Hu H, Pierce GN & Zhong G (1999) The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest 103: 747-753.
10. Kim MP, Gaydos CA, Wood BJ, Hardick JP, Zhang Y & Wahl LM (2005) Chlamydia pneumoniae enhances cytokine-stimulated human monocyte matrix metalloproteinases through a prostaglandin E2-dependent mechanism. Infect Immun 73: 632-634.
11. Kita T, Kume N, Ishii K, Horiuchi H, Arai H & Yokode M (1999) Oxidized LDL and expression of monocyte adhesion molecules. Diabetes Res Clin Pract 45: 123-126.
12. Kuo C, Takahashi N, Swanson AF, Ozeki Y & Hakomori S (1996) An N-linked high-mannose type oligosaccharide, expressed at the major outer membrane protein of Chlamydia trachomatis, mediates attachment and infectivity of the microorganism to HeLa cells. J Clin Invest 98: 2813-2818.
13. Kuo CC, Puolakkainen M, Lin TM, Witte M & Campbell LA (2002) Mannose-receptor positive and negative mouse macrophages differ in their susceptibility to infection by Chlamydia species. Microb Pathog 32: 43-48.
14. Kuo CC, Lee A & Campbell LA (2004) Cleavage of the N-linked oligosaccharide from the surfaces of Chlamydia species affects attachment and infectivity of the organisms in human epithelial and endothelial cells. Infect Immun 72: 6699-6701.
15. Kuo CC, Lee A, Jiang SJ, Yaraei K & Campbell LA (2007) Inoculation of Chlamydia pneumoniae or Chlamydia trachomatis with ligands that inhibit attachment to host cells reduces infectivity in the mouse model of lung infection: implication for anti-adhesive therapy. Microbes Infect 9: 1139-1141.
16. Li D & Mehta JL (2000) Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation 101: 2889-2895.
17. Li D, Liu L, Chen H, Sawamura T, Ranganathan S & Mehta JL (2003) LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells. Circulation 107: 612-617.
18. Lin FY, Lin YW, Huang CY et al. (2011) GroEL1, a heat shock protein 60 of Chlamydia pneumoniae, induces lectin-like oxidized low-density lipoprotein receptor 1 expression in endothelial cells and enhances atherogenesis in hypercholesterolemic rabbits. J Immunol 186: 4405-4414.
19. Mehta JL & Li D (2002) Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor. J Am Coll Cardiol 39: 1429-1435.
20. Moazed TC, Campbell LA, Rosenfeld ME, Grayston JT & Kuo CC (1999) Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J Infect Dis 180: 238-241.
21. Ogura S, Kakino A, Sato Y et al. (2009) Lox-1: the multifunctional receptor underlying cardiovascular dysfunction. Circ J 73: 1993-1999.
22. Puolakkainen M, Kuo CC & Campbell LA (2005) Chlamydia pneumoniae uses the mannose 6-phosphate/insulin-like growth factor 2 receptor for infection of endothelial cells. Infect Immun 73: 4620-4625.
23. Rodel J, Prochnau D, Prager K, Pentcheva E, Hartmann M & Straube E (2003) Increased production of matrix metalloproteinases 1 and 3 by smooth muscle cells upon infection with Chlamydia pneumoniae. FEMS Immunol Med Microbiol 38: 159-164.
24. Sawamura T, Kume N, Aoyama T et al. (1997) An endothelial receptor for oxidized low-density lipoprotein. Nature 386: 73-77.
25. Yoshida H, Kondratenko N, Green S, Steinberg D & Quehenberger O (1998) Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem J 334(Pt 1): 9-13.
26. Yoshida T, Koide N, Mori I, Ito H & Yokochi T (2006) Chlamydia pneumoniae infection enhances lectin-like oxidized low-density lipoprotein receptor (LOX-1) expression on human endothelial cells. FEMS Microbiol Lett 260: 17-22.
27. Yoshimoto R, Fujita Y, Kakino A, Iwamoto S, Takaya T & Sawamura T (2011) The discovery of LOX-1, its ligands and clinical significance. Cardiovasc Drugs Ther 25: 379-391.
28. Zhu H, Xia M, Hou M, Tang Z, Li Y, Ma J & Ling W (2005) Ox-LDL plays dual effect in modulating expression of inflammatory molecules through LOX-1 pathway in human umbilical vein endothelial cells. Front Biosci 10: 2585-2594.